TSX:APTXPharmaceuticals
Apotex Health (TSX:APTX) Stock May Trade At A Premium As Its Secondary Offering Grows
Apotex Health has delivered a strong year to date gain, yet the recent secondary share offering and shifting sentiment now put a spotlight on whether the current stock price lines up with what its sales can support. With the shares recently changing hands close to the bought deal offer price, investors are starting to ask how much of the business’s revenue story is already embedded in that valuation.
The stock is up 23.2% year to date, which raises the question of how much of Apotex Health’s...